Our mission is the promotion of global health through the development of effective vaccines that can be administered by tablet rather than by injection, providing for the simple and efficient distribution and administration of safe vaccines in any setting.
View Top Employees from Vaxart, Inc.Website | https://vaxart.com |
Ticker | VXRT |
Revenue | $4 million |
Funding | $15.8 million |
Employees | 146 (146 on RocketReach) |
Founded | 2004 |
Address | 290 Utah Ave, South San Francisco, California 94080, US |
Phone | (650) 550-3500 |
Fax | (650) 871-8580 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Biotechnology, Chemicals, Petrochemicals, Glass & Gases, Drug Discovery, Manufacturing, Science and Engineering, Pharmaceuticals, Health Care, Medical Device |
Web Rank | 9 Million |
Keywords | Innovative Vaccines |
Competitors | AlphaVax, Angiochem, CalciMedica, Mucosis, Profectus BioSciences, Inc |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Vaxart, Inc. employee's phone or email?
The Vaxart, Inc. annual revenue was $4 million in 2024.
Phillip Lee is the CFO of Vaxart, Inc..
146 people are employed at Vaxart, Inc..
Vaxart, Inc. is based in South San Francisco, California.
The NAICS codes for Vaxart, Inc. are [325414, 32, 32541, 3254, 325].
The SIC codes for Vaxart, Inc. are [28, 283].